Current status and prospect of treatments for recurrent hepatocellular carcinoma.

Yang, Yu-Qing; Wen, Zhen-Yu; Liu, Xiao-Yan; Ma, Zhen-Hu; Liu, Yan-E; Cao, Xue-Ying; Hou, Li; Xie, Hui.

Afiliação

Yang YQ; Department of Epidemiology and Biostatistics, Jilin University, Changchun 130021, Jilin Province, China.
Wen ZY; Department of Occupational and Environmental Health, Jilin University, Changchun 130021, Jilin Province, China.
Liu XY; Senior Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Ma ZH; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Liu YE; Department of Epidemiology and Biostatistics, Jilin University, Changchun 130021, Jilin Province, China.
Cao XY; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Hou L; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Xie H; Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China. xh302jr@126.com.

World J Hepatol ; 15(2): 129-150, 2023 Feb 27.

Article em En | MEDLINE | ID: mdl-36926237